313 related articles for article (PubMed ID: 33775745)
1. Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison.
Setién-Suero E; Ortiz-García de la Foz V; Suárez-Pinilla P; Crespo-Facorro B; Ayesa-Arriola R
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110309. PubMed ID: 33775745
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
[TBL] [Abstract][Full Text] [Related]
5. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia.
Maat A; Cahn W; Gijsman HJ; Hovens JE; Kahn RS; Aleman A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):575-84. PubMed ID: 24418213
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study.
Juncal-Ruiz M; Riesco-Dávila L; Ortiz-García de la Foz V; Martínez-Garcia O; Ramírez-Bonilla M; Ocejo-Viñals JG; Leza JC; López-Hoyos M; Crespo-Facorro B
Schizophr Res; 2018 Dec; 202():226-233. PubMed ID: 29941296
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
8. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.
Trampush JW; Lencz T; DeRosse P; John M; Gallego JA; Petrides G; Hassoun Y; Zhang JP; Addington J; Kellner CH; Tohen M; Burdick KE; Goldberg TE; Kane JM; Robinson DG; Malhotra AK
Schizophr Bull; 2015 Nov; 41(6):1237-47. PubMed ID: 26409223
[TBL] [Abstract][Full Text] [Related]
9. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
Matsuda Y; Sato S; Iwata K; Furukawa S; Hatsuse N; Watanabe Y; Anzai N; Kishimoto T; Ikebuchi E
Psychiatry Clin Neurosci; 2014 Jun; 68(6):425-31. PubMed ID: 24506576
[TBL] [Abstract][Full Text] [Related]
10. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.
Ayesa-Arriola R; Rodríguez-Sánchez JM; Pérez-Iglesias R; Roiz-Santiáñez R; Martínez-García O; Sánchez-Moreno J; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
Psychopharmacology (Berl); 2013 Jun; 227(4):615-25. PubMed ID: 23455591
[TBL] [Abstract][Full Text] [Related]
11. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
[TBL] [Abstract][Full Text] [Related]
12. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.
Goldberg TE; Burdick KE; McCormack J; Napolitano B; Patel RC; Sevy SM; Goldman R; Lencz T; Malhotra AK; Kane JM; Robinson DG
Schizophr Res; 2009 Feb; 107(2-3):262-6. PubMed ID: 19042105
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.
Frazier JA; Giuliano AJ; Johnson JL; Yakutis L; Youngstrom EA; Breiger D; Sikich L; Findling RL; McClellan J; Hamer RM; Vitiello B; Lieberman JA; Hooper SR
J Am Acad Child Adolesc Psychiatry; 2012 May; 51(5):496-505. PubMed ID: 22525956
[TBL] [Abstract][Full Text] [Related]
14. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
Janicak PG; Glick ID; Marder SR; Crandall DT; McQuade RD; Marcus RN; Eudicone JM; Assunção-Talbott S
J Clin Psychiatry; 2009 Jan; 70(1):25-35. PubMed ID: 19192472
[TBL] [Abstract][Full Text] [Related]
15. Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
Higuchi Y; Sumiyoshi T; Seo T; Miyanishi T; Kawasaki Y; Suzuki M
PLoS One; 2013; 8(1):e54080. PubMed ID: 23349791
[TBL] [Abstract][Full Text] [Related]
16. Trajectories and antecedents of treatment response over time in early-episode psychosis.
Levine SZ; Rabinowitz J
Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
[TBL] [Abstract][Full Text] [Related]
17. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
[TBL] [Abstract][Full Text] [Related]
18. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
Robinson DG; Gallego JA; John M; Petrides G; Hassoun Y; Zhang JP; Lopez L; Braga RJ; Sevy SM; Addington J; Kellner CH; Tohen M; Naraine M; Bennett N; Greenberg J; Lencz T; Correll CU; Kane JM; Malhotra AK
Schizophr Bull; 2015 Nov; 41(6):1227-36. PubMed ID: 26338693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
